Authors
Samuel Arthur Ameyaw, Johnson Addo Ameyaw
Published in
Journal of imaging informatics in medicine. Oct 13, 2026. Epub Oct 13, 2026.
Abstract
The translation of deep learning architectures from controlled experimental settings into real-world cancer diagnostics is heavily bottlenecked by domain shift and demographic bias. While models routinely achieve near-perfect retrospective performance on internal datasets, validation across external multicenter cohorts incurs a systemic and severe performance degradation, with an average metric drop of 0.16 AUC. This review provides a comprehensive metasynthesis of contemporary algorithmic mitigation paradigms designed to alleviate distribution discrepancies, evaluating techniques ranging from classical stain normalization and adversarial feature alignment to test-time adaptation and large-scale self-supervised pathology foundation models. Our analysis reveals a critical dichotomy between raw diagnostic performance and algorithmic equity: current optimization frameworks that successfully elevate aggregate macro metrics frequently do so by obscuring or actively exacerbating underlying demographic and subpopulation disparities. To achieve safe, equitable, and universally reliable clinical artificial intelligence, the field must transcend static validation habits. We outline a future roadmap anchored on three critical axes: establishing intersectional disparity indices as primary regulatory endpoints, standardizing multivendor metadata-rich benchmarks, and prioritizing.
PMID:
42870152
Bibliographic data and abstract were imported from PubMed on 14 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 20
- Comments 0